₹417.45
▼ -1.93 -0.46%
17 Jul 2026
NSE Listed
Syngene International Ltd. (SYNGENE)
Volume: 7,86,042Avg Vol 1W: 8,27,770.4Avg Vol 1M: 9,22,665.452W Range:₹380₹728.6
Key Ratios
Checked 8h agoMarket Cap₹16,932 Cr
Current Price₹417.45
Previous Close₹419.38
High / Low (52w)₹728.6 / ₹380
Volume7,86,042
Avg Vol (1W)8,27,770.4
Avg Vol (1M)9,22,665.4
Stock P/E62.43
Book Value₹115.25
Dividend Yield—
ROE10.6%
ROA—
Revenue (TTM)₹3,714 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹11.63
P/B6.3
Debt / Equity0.07
50 DMA₹442.18
200 DMA₹516.16
Day change-0.46%
Price Chart
₹417.45▼ 37.73% · 1Y
2025-07-172026-07-16
20-day avg volume: 9.2L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 62.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹790 Cr | ₹891 Cr | ₹944 Cr | ₹1,018 Cr | ₹875 Cr | ₹911 Cr | ₹917 Cr | ₹1,037 Cr |
| EBITDA | ₹81 Cr | ₹150 Cr | ₹193 Cr | ₹256 Cr | ₹113 Cr | ₹98 Cr | ₹111 Cr | ₹214 Cr |
| Net Profit | ₹76 Cr | ₹106 Cr | ₹131 Cr | ₹183 Cr | ₹87 Cr | ₹67 Cr | ₹15 Cr | ₹148 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,901 Cr | ₹2,094 Cr | ₹2,249 Cr | ₹2,712 Cr | ₹3,264 Cr | ₹3,579 Cr | ₹3,714 Cr | ₹3,809 Cr |
| EBITDA | ₹448 Cr | ₹480 Cr | ₹462 Cr | ₹539 Cr | ₹639 Cr | ₹679 Cr | ₹681 Cr | ₹536 Cr |
| Net Profit | ₹332 Cr | ₹412 Cr | ₹405 Cr | ₹396 Cr | ₹464 Cr | ₹510 Cr | ₹496 Cr | ₹317 Cr |
| EPS | 8.36 | 10.35 | 10.11 | 9.82 | 11.51 | 12.69 | 12.34 | 7.87 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,704 Cr | ₹4,163 Cr | ₹4,883 Cr | ₹5,564 Cr | ₹5,831 Cr | ₹6,152 Cr | ₹6,796 Cr | ₹7,055 Cr |
| Total Liabilities | ₹1,735 Cr | ₹1,987 Cr | ₹2,062 Cr | ₹2,266 Cr | ₹2,213 Cr | ₹1,894 Cr | ₹2,069 Cr | ₹2,216 Cr |
| Equity | ₹1,968 Cr | ₹2,176 Cr | ₹2,821 Cr | ₹3,298 Cr | ₹3,618 Cr | ₹4,258 Cr | ₹4,727 Cr | ₹4,839 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹727 Cr | ₹784 Cr | ₹785 Cr | ₹686 Cr | ₹960 Cr | ₹1,167 Cr | ₹1,283 Cr | ₹985 Cr |
| Investing | ₹-646 Cr | ₹-428 Cr | ₹-628 Cr | ₹-611 Cr | ₹-656 Cr | ₹-496 Cr | ₹-745 Cr | ₹-860 Cr |
| Financing | ₹-72 Cr | ₹-225 Cr | ₹58 Cr | ₹-31 Cr | ₹-342 Cr | ₹-551 Cr | ₹-142 Cr | ₹-215 Cr |
| Free Cash Flow | ₹727 Cr | ₹784 Cr | ₹785 Cr | ₹686 Cr | ₹960 Cr | ₹1,167 Cr | ₹1,283 Cr | ₹985 Cr |
Shareholding
Promoter 52.68% Institutions 40.34% Public 6.98%
Efficiency & Working Capital
ROCE9.7%
Interest Coverage10.9
Dividend Payout—
Debtor Days50 d
Inventory Days14 d
Payable Days34 d
Cash Conversion Cycle30 d
Working Capital Days63 d
Shareholding Details
As of 2026-03-31
Promoter52.7%
FII13.9%
DII26.4%
Institutions40.3%
Public7%
Promoter Pledge0%
No. of Shareholders1,35,605
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.8% | 54.8% | 54.8% | 54.8% | 54.7% | 54.7% | 52.7% | 52.7% | 52.7% | 52.7% | 52.7% | 52.7% |
| FIIs | 23.2% | 23.6% | 21.2% | 20.9% | 20.6% | 20.7% | 20.6% | 19.5% | 16.5% | 16.3% | 15% | 13.9% |
| DIIs | 11.2% | 9.9% | 13.1% | 15.8% | 16.8% | 17.5% | 19.5% | 21.5% | 24% | 24.6% | 25.8% | 26.4% |
| Public | 10.8% | 11.7% | 10.9% | 8.5% | 7.8% | 7.1% | 7.1% | 6.3% | 6.8% | 6.4% | 6.5% | 7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,25,455 | 1,25,992 | 1,21,880 | 1,15,850 | 1,20,018 | 1,07,338 | 1,28,806 | 1,25,090 | 1,42,310 | 1,36,061 | 1,31,750 | 1,35,605 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Biocon Limited | Shareholding of Promoter and Promoter Group | 52.4% | 21.12 Cr |
| Nippon Life India Trustee Ltd-a/c Nippon India Ret | Public Shareholding | 6% | 2.41 Cr |
| Icici Prudential S&p Bse 500 Etf | Public Shareholding | 5.4% | 2.17 Cr |
| Dsp Arbitrage Fund | Public Shareholding | 4.8% | 1.91 Cr |
| Mirae Asset Multicap Fund | Public Shareholding | 3.3% | 1.32 Cr |
| Government Of Singapore | Public Shareholding | 2.9% | 1.16 Cr |
| Government Pension Fund Global | Public Shareholding | 1.8% | 73,42,967 |
| Lic New Pension Plus Growth Fund | Public Shareholding | 1.8% | 71,83,419 |
| Uti Balanced Advantage Fund | Public Shareholding | 1.2% | 46,67,740 |
| Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar) | Shareholding of Promoter and Promoter Group | 0.3% | 10,53,633 |
| Kiran Mazumdar Shaw | Shareholding of Promoter and Promoter Group | 0% | 21,964 |
| Ravi Rasendra Mazumdar | Shareholding of Promoter and Promoter Group | 0% | 8,806 |
| Biocon Research Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dev Mazumdar | Shareholding of Promoter and Promoter Group | 0% | 13,686 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Kiran Mazumdar Shaw | 0 | 0% | 2026-03-31 |
| Ravi Rasendra Mazumdar | 0 | 0% | 2026-03-31 |
| Biocon Limited | 0 | 0% | 2026-03-31 |
| Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar) | 0 | 0% | 2026-03-31 |
| Biocon Research Limited | 0 | 0% | 2026-03-31 |
| Dev Mazumdar | 0 | 0% | 2026-03-31 |
| Icici Prudential S&p Bse 500 Etf | 0 | 0% | 2026-03-31 |
| Dsp Arbitrage Fund | 0 | 0% | 2026-03-31 |
| Nippon Life India Trustee Ltd-a/c Nippon India Ret | 0 | 0% | 2026-03-31 |
| Uti Balanced Advantage Fund | 0 | 0% | 2026-03-31 |
| Mirae Asset Multicap Fund | 0 | 0% | 2026-03-31 |
| Lic New Pension Plus Growth Fund | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Kiran Mazumdar Shaw | Executive Chairman | 2026 |
| Peter John Bains | Managing Director & CEO | 2026 |
| Catherine Patricia Rosenberg | Non-Exec & Non-Independent Dir | 2026 |
| Vinita Bali | Non-Exec & Non-Independent Dir | 2026 |
| Kush Parmar | Independent Non Exe. Director | 2026 |
| Sharmila Karve | Lead Independent Non Executive Director | 2026 |
| Nilanjan Roy | Independent Non Exe. Director | 2026 |
| Manja Boerman | Independent Non Exe. Director | 2026 |
| Sanjaya Singh | Independent Non Exe. Director | 2026 |
| Suresh Narayanan | Independent Non Exe. Director | 2026 |
| Arun Suresh Chandavarkar | Independent Director | 2026 |
| Chethan Yogesh | Company Sec. & Compli. Officer | 2026 |
| Vijaya Chandru | Independent Director | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Providing contract research and man | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹136 Cr | 4% |
| United States of America | ₹2,198 Cr | 64.2% |
| Europe | ₹952 Cr | 27.8% |
| Rest of the World | ₹139 Cr | 4.1% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 500 | 403 | 403 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-29 | Board Meetings | — |
| dividend | 2026-06-25 | ₹1.25 (12.5%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 281 | 0 | 0 | 33 | 230 | 597 |
| 2026 | 257 | 0 | 0 | 33 | 21 | 336 |
| 2026 | 24 | 0 | 0 | 0 | 209 | 261 |
Insider / Designated-Person Trades
30 recent disclosure(s)
ANJAN CHAKRABARTIDisposal · 6,190
ANJAN CHAKRABARTIDisposal · 27,200
ANJAN CHAKRABARTIAcquisition · 58,390
BIOCON LIMITEDDisposal · 80,00,000
DEEPAK VENKATRAMANDisposal · 600
DEEPAK VENKATRAMANDisposal · 600
Substantial Acquisitions (SAST)
2 disclosure(s)
Market08/05/2025 · 3,61,572
Market10/12/2024 · 80,00,000
Company Information
Incorporated1993
ChairmanKiran Mazumdar Shaw
AuditorB S R & Co LLP
Investor Email[email protected]; Mayank.Verma@syngeneintl
📍 Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search